Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial-Reference-Cited by-同舟云学术

Adoptive immunotherapy to lower postsurgical recurrence rates of hepatocellular carcinoma: a randomised trial

Published:2000-09 Issue:9232 Volume:356 Page:802-807
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Takayama Tadatoshi,Sekine Teruaki,Makuuchi Masatoshi,Yamasaki Susumu,Kosuge Tomoo,Yamamoto Junji,Shimada Kazuaki,Sakamoto Michiie,Hirohashi Setsuo,Ohashi Yasuo,Kakizoe Tadao

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. Hepatocellular carcinoma;Schafer;Lancet,1999

2. Early hepatocellular carcinoma as an entity with a high rate of surgical cure;Takayama;Hepatology,1998

3. Treatment of hepatocellular carcinoma;Bruix;Hepatology,1997

4. Intrahepatic recurrence after resection of hepatocellular carcinoma complicating cirrhosis;Belghiti;Ann Surg,1991

5. Hepatic resection for hepatocellular carcinoma: an audit of 343 patients;Lai;Ann Surg,1995

Cited by 766 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapy for hepatocellular carcinoma;JHEP Reports;2024-10

2. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside;Experimental Hematology & Oncology;2024-08-01

3. Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies;Cell Biochemistry and Function;2024-07

4. Role of liver resection in the era of advanced systemic therapy for hepatocellular carcinoma;Global Health & Medicine;2024-06-30

5. Advancements in Immunotherapeutic Treatments for Hepatocellular Carcinoma: Potential of Combination Therapies;International Journal of Molecular Sciences;2024-06-21